| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 42, 1460-1466, Copyright © 1996 by American Association for Clinical Chemistry
M Zaninotto, S Altinier, M Lachin, P Carraro and M Plebani
Laboratorio Centrale, Azienda Ospedaliera di Padova, Italy.
The aim of our study was to evaluate the clinical relevance of serum troponin I (TnI) as a marker of ischemic myocardial injury by using an automated fluoroenzymometric assay. The reference range for serum TnI was established by measuring serum TnI concentrations in blood from 75 healthy donors. The concentration was then compared with serum creatine kinase (CK) activity, CK-MB mass, and myoglobin concentrations in 20 patients with myocardial infarction diagnosed according to the WHO criteria, 20 patients with chest pain of nonischemic origin, 9 patients with unstable angina, 11 with stable angina, 11 patients with chronic muscular diseases, 6 patients with muscular trauma without chest contusion, and 13 patients with chronic renal disease. We found that: (a) 99% of the blood donors had TnI concentrations <0.26 microgram/L (detection limit of the assay in our study); (b) TnI values in acute myocardial infarction (AMI) patients 4 h after onset of chest pain showed a sensitivity of 0.769 and a specificity of 1.0 at a decisional concentration for AMI of 1 microgram/L, even in the presence of severe skeletal muscle injuries or renal diseases; (c) the increase in TnI concentrations after infarction (interquartile range 3.25-6 h) and the peak occurred later (interquartile range 11.5-24 h) than the rise found in myoglobin and CK-MB, but the increase persisted much longer (>96 h); (d) receiver-operating characteristic curve analysis showed the high diagnostic accuracy of TnI in diagnosing AMI even in patients in whom traditional biochemical markers are adversely influenced by underlying clinical situations.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  M. T. Sandri, D. Cardinale, L. Zorzino, R. Passerini, P. Lentati, A. Martinoni, G. Martinelli, and C. M. Cipolla Minor Increases in Plasma Troponin I Predict Decreased Left Ventricular Ejection Fraction after High-Dose Chemotherapy Clin. Chem., February 1, 2003; 49(2): 248 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Newman, Y. Olabiran, W. D. Bedzyk, S. Chance, E. G. Gorman, and C. P. Price Impact of Antibody Specificity and Calibration Material on the Measure of Agreement between Methods for Cardiac Troponin I Clin. Chem., June 1, 1999; 45(6): 822 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Polanczyk, T. H. Lee, E. F. Cook, R. Walls, D. Wybenga, G. Printy-Klein, L. Ludwig, G. Guldbrandsen, and P. A. Johnson Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain J. Am. Coll. Cardiol., July 1, 1998; 32(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sadony, M. Korber, G. Albes, V. Podtschaske, T. Etgen, T. Trosken, U. Ravens, and M. E. Scheulen Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. O'Brien, Y. Landt, and J. H. Ladenson Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay Clin. Chem., December 1, 1997; 43(12): 2333 - 2338. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
